NANJING, China, Jan. 4, 2024 /PRNewswire/ — On January 10, 2024, the GenScript Biotech Global Forum is set to inaugurate with grandeur during the 42nd J.P. Morgan Healthcare Conference in San Francisco, USA. The forum, themed " Innovations and Breakthroughs Shaping Tomorrow's Cell and Gene Therapies ," will take off from a fresh, multi-dimensional perspective, gathering leading figures from the biopharmaceutical innovation sector. This includes corporate titans, industry elites, FDA officials, and key players in the capital markets to jointly explore research and development as well as innovative opportunities for cell and gene therapy (GCT) products, and to collaboratively devise new strategies and prospects for the industry's future commercialization. The GenScript Biotech Global Forum will not only represent a significant step in the exploration of commercialization within the GCT industry but will also recalibrate the direction of its future development.